This page shows the publications co-authored by Ted Kaptchuk and Vikram Rangan.
Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain. 2021 09 01; 162(9):2428-2435.
Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline. Clin Gastroenterol Hepatol. 2022 Mar 23.
Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychol. 2022 Feb 04; 10(1):20.
Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Am J Gastroenterol. 2021 11 01; 116(11):2279-2285.
Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. J Clin Gastroenterol. 2021 Jun 07.
Placebo Response in Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019 12; 114(12):1838-1846.
Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation. Clin Gastroenterol Hepatol. 2018 11; 16(11):1738-1744.e1.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.